Department of Pediatrics, Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina, Chapel Hill, NC 7599, USA.
Free Radic Biol Med. 2012 Aug 15;53(4):721-9. doi: 10.1016/j.freeradbiomed.2012.05.037. Epub 2012 Jun 6.
Lung inflammation resulting from oxidant/antioxidant imbalance is a common feature of many lung diseases. In particular, the role of enzymes regulated by the NF-E2-related factor 2 transcription factor has recently received increased attention. Among these antioxidant genes, glutathione S-transferase Mu 1 (GSTM1) has been most extensively characterized because it has a null polymorphism that is highly prevalent in the population and associated with increased risk of inflammatory lung diseases. Present evidence suggests that GSTM1 acts through interactions with other genes and environmental factors, especially air pollutants. Here, we review GSTM1 gene expression and regulation and summarize the findings from epidemiological, clinical, animal, and in vitro studies on the role played by GSTM1 in lung inflammation. We discuss limitations in the existing knowledge base and future perspectives and evaluate the potential of pharmacologic and genetic manipulation of the GSTM1 gene to modulate pulmonary inflammatory responses.
肺炎症反应是许多肺部疾病的共同特征,源于氧化应激/抗氧化失衡。特别是,受核因子 E2 相关因子 2 转录因子调控的酶的作用最近受到了更多关注。在这些抗氧化基因中,谷胱甘肽 S-转移酶 Mu1(GSTM1)的特征最为广泛,因为它存在一种缺失的多态性,在人群中非常普遍,与肺部炎症性疾病的风险增加有关。目前的证据表明,GSTM1 通过与其他基因和环境因素(特别是空气污染物)的相互作用发挥作用。在这里,我们回顾了 GSTM1 基因的表达和调控,并总结了流行病学、临床、动物和体外研究中关于 GSTM1 在肺炎症中的作用的发现。我们讨论了现有知识库中的局限性和未来的展望,并评估了药物和遗传调控 GSTM1 基因以调节肺部炎症反应的潜力。